Keiichi Igarashi Hanaoka

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto et al. · JAMA · 2019 · 834 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki et al. · JAMA Cardiology · 2022 · 300 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores

Masahiro Natsuaki, Takeshi Morimoto, Kyohei Yamaji et al. · Journal of the American Heart Association · 2018 · 196 citations · Full text

Medicine, Cardiology, Surgery +17

Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation

Yukiko Matsumura‐Nakano, Satoshi Shizuta, Akihiro Komasa et al. · Circulation · 2019 · 191 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018

Yukio Ozaki, Yuki Katagiri, Yoshinobu Onuma et al. · Cardiovascular Intervention and Therapeutics · 2018 · 92 citations · Full text

Medicine, Cardiology, Internal Medicine +14